Authors : Surabhi; Dr. Mansi Chaudhary

Volume/Issue : Volume 10 - 2025, Issue 12 - December

Google Scholar : https://tinyurl.com/49pasvct

Scribd : https://tinyurl.com/m645rwtx

DOI : https://doi.org/10.38124/ijisrt/25dec820

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Cordyceps, especially Cordyceps sinensis and Cordyceps militaris, is a very interesting fungus that belongs to the entomopathogenic fungi group and has been gaining limelight in the past few years because of its varied bioactive compounds and medicinal properties. Cordyceps has been traditionally used in Asian medicinal practices for many years and is currently in demand worldwide for its nutritional and pharmaceutical uses. This review aims to comprehensively discuss the taxonomy, biological, bioactive compounds, pharmacological properties, cultivation, and medicinal importance of Cordyceps species. It will give special focus on cordycepin, polysaccharides, and other metabolites that are mainly responsible for the immunomodulatory, anti-inflammatory, antioxidant, and anti-tumor effects of these species. However, despite the medicinal properties, there are many issues associated with its sustainability, standardization, and validation, and this review will highlight the future research aspects of Cordyceps that are required to fully tap its medicinal and commercial potential.

Keywords : Cordyceps sinensis, Cordyceps militaris, Entomopathogenic fungi, Medicinal Properties.

References :

1. Chen, Y., Guo, S., & Wang, J. (2013). Structure and immunomodulatory activity of polysaccharides from Cordyceps militaris. International Journal of Biological Macromolecules, 57, 20–26.
2. Holliday, J., & Cleaver, M. (2008). Medicinal value of the caterpillar fungi species of the genus Cordyceps. Journal of Alternative and Complementary Medicine, 14(4), 405–416.
3. Hughes, D. P., Andersen, S. B., Hywel-Jones, N. L., Himaman, W., Billen, J., & Boomsma, J. J. (2011). Behavioral mechanisms and morphological symptoms of zombie ants dying from fungal infection. BMC Ecology, 11, 13.
4. Hywel-Jones, N. L. (2002). Cordyceps and the clavicipitalean fungi: Relationships and evolution. Mycological Research, 106(6), 656–670.
5. Jin, Y., Meng, X., Qiu, Z., Su, Y., Yu, P., & Qu, P. (2018). Cordycepin inhibits cancer cell proliferation via AMPK–mTOR signaling pathway. Molecular Medicine Reports, 18, 4773–4780.
6. Li, S. P., Yang, F. Q., & Tsim, K. W. (2006). Quality control of Cordyceps sinensis, a valued traditional Chinese medicine. Journal of Pharmaceutical and Biomedical Analysis, 41(5), 1571-1584.
7. Nakamura, K., Konoha, K., Yamaguchi, Y., Kagota, S., Shinozuka, K., & Kunitomo, M. (1999). Inhibitory effects of cordycepin on tumor growth. Biological & Pharmaceutical Bulletin, 22(7), 713–719.
8. Paterson, R. R. M. (2008). Cordyceps: A traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry, 69(7), 1469-1495.
9. Quandt, C. A., Kepler, R. M., Gams, W., Araújo, J. P. M., Ban, S., Evans, H. C., & Spatafora, J. W. (2014). Phylogenetic-based nomenclatural proposals for Ophiocordycipitaceae. IMA Fungus, 5(1), 121–134.
10. Ramesh, R., Shashidhar, M. G., Giridhar, P., & Manohar, B. (2020). Therapeutic potential and immunomodulatory effects of Cordyceps species: A review. Journal of Ethnopharmacology, 257, 112–123.
11. Shrestha, U. B., & Sung, G. H. (2005). Cordyceps sinensis: A valued traditional medicine and its ecology in the Himalayan region. In Proceedings of the International Symposium on Medicinal Mushrooms (pp. 89-98).
12. Sung, G. H., Hywel-Jones, N. L., Sung, J. M., Luangsa-ard, J. J., Shrestha, B., & Spatafora, J. W. (2007). Phylogenetic classification of Cordyceps and the clavicipitaceous fungi. Studies in Mycology, 57, 5-59.
13. Tuli, H. S., Sharma, A. K., Sandhu, S. S., & Kashyap, D. (2014). Cordycepin: A bioactive metabolite with therapeutic potential. Life Sciences, 93(23), 863-869.
14. Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60, 258–274.
15. Winkler, D. (2008). Yartsa Gunbu (Cordyceps sinensis) and the fungal commodification of Tibet's rural economy. Economic Botany, 62(3), 291-305.
16. Wu, J. Y., Zhang, Q. X., & Leung, P. H. (2007). Inhibitory effects of Cordyceps sinensis on cytokine production. Journal of Ethnopharmacology, 110, 443–448.
17. Zhang, Z., Lv, G., Pan, H., Fan, L., & Fan, Y. (2012). Antidiabetic and antioxidant effects of Cordyceps polysaccharides. Evidence-Based Complementary and Alternative Medicine, 2012, Article ID 923232.
18. Zhao, C., Liu, Y., & Zhang, Q. (2014). Effects of Cordyceps on lipid metabolism and oxidative stress. Journal of Functional Foods, 6, 123–131.
19. Zhou, X., Gong, Z., Su, Y., et al. (2009). Medicinal uses of Cordyceps in traditional Chinese medicine and modern pharmacology. Journal of Ethnopharmacology, 126, 321–331.
20. Zhu, J. S., Halpern, G. M., & Jones, K. (1998). The scientific rediscovery of Cordyceps sinensis. Journal of Alternative and Complementary Medicine, 4(3), 289–303.